[Increased asthma fatality in chronic administration of beta agonists?].
作者信息
Geisler L S
出版信息
Dtsch Med Wochenschr. 1993 Feb 12;118(6):206-7.
PMID:8094666
Abstract
摘要
相似文献
1
[Increased asthma fatality in chronic administration of beta agonists?].[长期使用β受体激动剂会增加哮喘死亡率吗？]
Dtsch Med Wochenschr. 1993 Feb 12;118(6):206-7.
2
Beta-agonist therapy and asthma mortality in Japan.
Lancet. 1998 May 9;351(9113):1406-7. doi: 10.1016/S0140-6736(05)79446-0.
3
[Beta 2 agonists in asthma therapy should be reevaluated--concerning the dosage].[哮喘治疗中β2激动剂的剂量应重新评估]
Lakartidningen. 1991 Oct 30;88(44):3643-5.
4
Evidence based answers--is salmeterol safe in asthma?循证解答——沙美特罗用于哮喘是否安全？
Aust Fam Physician. 2006 Aug;35(8):625-6.
5
Regularly scheduled versus as-needed use of inhaled beta agonists in the treatment of asthma.在哮喘治疗中，吸入型β受体激动剂的定期使用与按需使用对比。
Clin Pharm. 1992 Oct;11(10):877-9.
6
Beta-agonists and death from asthma.
N Engl J Med. 1992 Jul 30;327(5):355-7.
7
Fenoterol inhalation: its associated risks and potential benefits when reducing serum potassium levels.非诺特罗吸入剂：降低血清钾水平时的相关风险及潜在益处
Clin Nephrol. 1998 Jun;49(6):390.
8
International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.
J Clin Epidemiol. 1997 Mar;50(3):321-8. doi: 10.1016/s0895-4356(96)00375-7.
9
Asthma deaths in New Zealand: whodunnit?
Lancet. 1995 Jan 7;345(8941):2-3. doi: 10.1016/s0140-6736(95)91143-x.
10
The proper role of beta 2-adrenergic agonists in the treatment of children with asthma.
Pediatrics. 1992 Oct;90(4):639-40.
Zotero 插件